RespireRx Pharmaceuticals Inc (fka RSPI)

[atheroprevent]

Thanks for the update Maximalexander and gfp.

I have another patient just diagnosed with OSA this week, who will shortly undergo CPAP titration.

I suspect, he would jump at the chance to participate in the OSA study (even fly at his own expense to London), for a chance to avoid CPAP. I don't think he has any of the exclusionary characteristics for the SA study. Unfortunately he developed mild cognitive impairment this year.

If Cor survives to do a longer term ampa SA study, it would be interesting to assess cognition in this patient before and after amp SA enrollment.

Alas, in the shadow if the FDA, everything changes.
.... so I lose my license to practice for unauthorized research, even if n=1.
.... so my patient (along with a million others) is "protected", but dammed to the natural history of his disease.